The Europe electrophysiology market is expected to grow from US$ 2,398.85 million in 2022 to US$ 4,234.94 million by 2028; it is estimated to grow at a CAGR of 9.9% from 2022 to 2028.
According to the World Health Organization (WHO), cardiovascular disease (CVD) is one of the leading causes of death across the region. Family history, ethnicity, age, tobacco use, high blood pressure (hypertension), high cholesterol, lack of exercise, unhealthy diet, alcohol consumption, and diseases such as dyslipidemia, obesity, and diabetes are contributing to the rising incidence of CVD, such as stroke. Atrial fibrillation (AF) is the most commonly diagnosed arrhythmia in clinical practice, affecting over ~886,000 new people in Europe each year. According to the US Census Bureau report on the burden of atrial fibrillation, Europe is expected to register the highest number of patients with AF by 2050. So, the rising number of incidences of target diseases and procedures is expected to drive the market growth.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe electrophysiology market at a substantial CAGR during the forecast period.
According to the World Health Organization (WHO), cardiovascular disease (CVD) is one of the leading causes of death across the region. Family history, ethnicity, age, tobacco use, high blood pressure (hypertension), high cholesterol, lack of exercise, unhealthy diet, alcohol consumption, and diseases such as dyslipidemia, obesity, and diabetes are contributing to the rising incidence of CVD, such as stroke. Atrial fibrillation (AF) is the most commonly diagnosed arrhythmia in clinical practice, affecting over ~886,000 new people in Europe each year. According to the US Census Bureau report on the burden of atrial fibrillation, Europe is expected to register the highest number of patients with AF by 2050. So, the rising number of incidences of target diseases and procedures is expected to drive the market growth.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe electrophysiology market at a substantial CAGR during the forecast period.
Europe Electrophysiology Market Segmentation
The Europe electrophysiology market is segmented based on product, indication, and country.- Based on product, the market is segmented into electrophysiology ablation catheters, electrophysiology laboratory devices, electrophysiology diagnostic catheters, access devices, and others. The electrophysiology laboratory devices segment dominated the market in 2022 and electrophysiology ablation catheters segment is expected to be fastest growing during forecast period.
- Based on indication, the market is segmented into atrial fibrillation (AF), atrial flutter, atrioventricular nodal reentry tachycardia (AVNRT), wolff-parkinson-white syndrome (WPW), and others. The atrial fibrillation (AF) segment dominated the market in 2022 and is expected to be fastest growing during forecast period.
- Based on country, the Europe electrophysiology market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe.
Table of Contents
1. Introduction
3. Research Methodology
4. Europe Electrophysiology Market - Market Landscape
5. Europe Electrophysiology Market- Key Market Dynamics
6. Electrophysiology Market- Europe Analysis
7. Europe Electrophysiology Market Analysis - By Product
8. Europe Electrophysiology Market Analysis - By Indication
9. Europe Electrophysiology Market - Country Analysis
10. Europe Electrophysiology Market-Industry Landscape
11. Company Profiles
12. Appendix
Companies Mentioned
- Abbott
- Biotronik, Inc.
- Boston Scientific Corporation
- CardioFocus
- GE Healthcare
- Johnson & Johnson Services, Inc.
- Koninklijke Philips N.V.
- Medtronic
- MicroPort Scientific Corporation
- Siemens Healthineers AG
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 144 |
| Published | September 2022 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 2398.85 Million |
| Forecasted Market Value ( USD | $ 4234.94 Million |
| Compound Annual Growth Rate | 9.9% |
| Regions Covered | Europe |
| No. of Companies Mentioned | 10 |
